Keywords: ترکیب دوز ثابت; tuberculosis; fixed dose combination; isonicotinyl hydrazone; isoniazid; pyrazinamide; rifampicin; ethambutol dihydrochloride;
مقالات ISI ترکیب دوز ثابت (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ترکیب دوز ثابت; The trial was registered under NCT02433834 at; http://www.clinicaltrials.gov; Asthma; Co-suspension delivery technology; Glycopyrronium; Inhaled corticosteroid use; Metered dose inhaler; ACQ-5; Asthma Control Questionnaire-5; AE; adverse event; AUC0-3;
Keywords: ترکیب دوز ثابت; Spray drying; Solid dispersion; Amorphous; Poorly soluble drugs; Formulation; AFM; Atomic force microscopy; ANN; Artificial neural networks; ANOVA; Analysis of variance; API; Active pharmaceutical ingredient; ASD; Amorphous solid dispersion; ATC; Atorvast
Keywords: ترکیب دوز ثابت; PolyPill; Multidrug delivery; Fixed dose combination; Patient compliance; Drug delivery and drug development;
Keywords: ترکیب دوز ثابت; Mini-tablets; Orally disintegrating mini-tablets; Drug delivery tool; Dose flexibility; Fixed dose combination; Content uniformity; Physico-mechanical attributes;
Keywords: ترکیب دوز ثابت; dual-chamber systems; dual-chamber cartridge; dual-chamber syringe; biologics; freeze-drying; aseptic processing; biopharmaceutical; small volume parenterals; home care; fixed dose combination;
Keywords: ترکیب دوز ثابت; KAAD; Catholics Academics Ausländer-Dienst; BfArM; Bundesinstut für Arzneimeittel und Medizinprodukte; TFDA; Tanzania Food and Drugs Authority; QC; quality control; API; active pharmaceutical ingredient; RP-HPLC; reverse phase- high performance liquid c
Keywords: ترکیب دوز ثابت; Intra-abdominal infections; Piperacillin/Tazobactam; Fixed dose combination; Pharmacoeconomic analysis;
Keywords: ترکیب دوز ثابت; amorphous; solubility; co-amorphous; formulation; supersaturation; fixed dose combination; diffusion; liquid-liquid phase separation;
Keywords: ترکیب دوز ثابت; Biofilm; Dry powder inhaler; Endpoint; Fixed dose combination; Nebulizer; Partial liquid ventilation; Tolerability;
Keywords: ترکیب دوز ثابت; Alfuzosin; Solifenacin; Fixed dose combination; Bioequivalence; 90% Confidence interval; Pharmacokinetic study;
Comparison of Adherence to Glimepiride/Metformin Sustained Release Once-daily Versus Glimepiride/Metformin Immediate Release BID Fixed-combination Therapy Using the Medication Event Monitoring System in Patients With Type 2 Diabetes
Keywords: ترکیب دوز ثابت; fixed dose combination; MEMS; sulfonylurea; glimepiride;
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi
Keywords: ترکیب دوز ثابت; Umeclidinium (PubChem CID: 11519070); vilanterol (PubChem CID: 10184665); umeclidinium/vilanterol (PubChem CID: 71300746); Umeclidinium; Vilanterol; Fixed dose combination; Synergistic interaction; Isolated bronchi; COPD;
Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration
Keywords: ترکیب دوز ثابت; Cidofovir; Cyclodextrin; Fixed dose combination; Inkjet printing; Nanoparticle; Paclitaxel;
Simultaneous determination of rifampicin, isoniazid, pyrazinamide and ethambutol in 4-FDC tablet by Raman spectroscopy associated to chemometric approach
Keywords: ترکیب دوز ثابت; Raman spectroscopy; Estimation of antituberculosis drugs; PLS approach; Fixed dose combination;
Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters
Keywords: ترکیب دوز ثابت; Ezetimibe (PubChem CID: 150311); Lovastatin (PubChem CID: 53232); Lovastatin hydroxyacid (PubChem CID: 64727); Eudragit L100® (PubChem CID: 6658); Eudragit L100-55® (PubChem CID: 107665); Ezetimibe; Lovastatin; Amorphous solid dispersions; Fixed dose co
Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery
Keywords: ترکیب دوز ثابت; Brittle matrix powder; Fixed dose combination; Co-deposition; Salmeterol xinafoate; Mometasone furoate; Thin-film freezing;
Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance
Keywords: ترکیب دوز ثابت; Co-formulated solid dispersion; Hot melt extrusion; Artemether; Lumefantrine; Fixed dose combination; Atomic force microscopy; Raman spectroscopy; 2D NMR; Bioavailability
Pharmacokinetic Interactions Between Eperisone Hydrochloride and Aceclofenac: A Randomized, Open-Label, Crossover Study of Healthy Korean Men
Keywords: ترکیب دوز ثابت; aceclofenac; drug-drug interaction; eperisone hydrochloride; fixed dose combination;
New formulation approaches to improve solubility and drug release from fixed dose combinations: Case examples pioglitazone/glimepiride and ezetimibe/simvastatin
Keywords: ترکیب دوز ثابت; Fixed dose combination; Solubility improvement; Dissolution enhancement; Solid dispersions; Ternary comlexes